Post by icemandios on Feb 22, 2018 16:51:59 GMT
Regulators need to rethink ‘current’ GMP requirements, says ex-FDA exec
22-Feb-2018 By Flora Southey
In the days of personalised medicine, 3D printing and nanotechnology, consultant David Chesney says regulators must “keep pace” to redefine current good manufacturing practice.
www.in-pharmatechnologist.com/Headlines/Regulatory-Safety/Regulators-need-to-rethink-current-GMP-requirements-says-ex-FDA-exec
22-Feb-2018 By Flora Southey
In the days of personalised medicine, 3D printing and nanotechnology, consultant David Chesney says regulators must “keep pace” to redefine current good manufacturing practice.
www.in-pharmatechnologist.com/Headlines/Regulatory-Safety/Regulators-need-to-rethink-current-GMP-requirements-says-ex-FDA-exec